Hostname: page-component-7b7567c8c-lpg2g Total loading time: 0 Render date: 2026-11-15T15:09:45.119Z Has data issue: false hasContentIssue false

Tardive dyskinesia – how is it prevented and treated?

Published online by Cambridge University Press:  02 January 2018

Denise Duncan*
Affiliation:
Maudsley Hospital
Harry McConnell
Affiliation:
Institute of Psychiatry
David Taylor
Affiliation:
Maudsley Hospital Denmark Hill London SE5 8AZ
*
∗ Correspondence
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

Tardive dyskinesia (TD), literally meaning a late occurring, abnormal movement disorder, was first described by Schonecker in 1957, about five years after the discovery of chlorpromazine (cited in Kane, 1992). TD generally occurs after long-term antipsychotic therapy: Kane et al (1984) reported that the incidence was increased with each subsequent year of exposure to antipsychotics, starting with an incidence of 5% after one year of exposure and increasing by 5% each subsequent year. Certainly, the prevalence of TD has increased over the last 20 years, probably as the result of more patients being exposed to antipsychotics for longer periods.

Information

Type
Drug Information Quarterly
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © 1997 The Royal College of Psychiatrists
Submit a response

eLetters

No eLetters have been published for this article.